198 related articles for article (PubMed ID: 14521991)
1. Apolipoprotein E4 decreases whereas apolipoprotein E3 increases the level of secreted amyloid precursor protein after closed head injury.
Ezra Y; Oron L; Moskovich L; Roses AD; Beni SM; Shohami E; Michaelson DM
Neuroscience; 2003; 121(2):315-25. PubMed ID: 14521991
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.
Hartman RE; Laurer H; Longhi L; Bales KR; Paul SM; McIntosh TK; Holtzman DM
J Neurosci; 2002 Dec; 22(23):10083-7. PubMed ID: 12451108
[TBL] [Abstract][Full Text] [Related]
4. Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice.
Ophir G; Meilin S; Efrati M; Chapman J; Karussis D; Roses A; Michaelson DM
Neurobiol Dis; 2003 Feb; 12(1):56-64. PubMed ID: 12609489
[TBL] [Abstract][Full Text] [Related]
5. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.
Fitz NF; Wolfe CM; Playso BE; Biedrzycki RJ; Lu Y; Nam KN; Lefterov I; Koldamova R
Mol Neurodegener; 2020 Jul; 15(1):41. PubMed ID: 32703241
[TBL] [Abstract][Full Text] [Related]
6. Secretion of the amyloid precursor protein is elevated isoform specifically by apolipoprotein E4.
Oron L; Efrati M; Michaelson DM
J Neural Transm Suppl; 2000; 59():163-9. PubMed ID: 10961428
[TBL] [Abstract][Full Text] [Related]
7. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.
Carter DB; Dunn E; McKinley DD; Stratman NC; Boyle TP; Kuiper SL; Oostveen JA; Weaver RJ; Boller JA; Gurney ME
Ann Neurol; 2001 Oct; 50(4):468-75. PubMed ID: 11601499
[TBL] [Abstract][Full Text] [Related]
9. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
10. Astrocytes down-regulate neuronal beta-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner.
Vincent B; Smith JD
Eur J Neurosci; 2001 Jul; 14(2):256-66. PubMed ID: 11553277
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities.
Sabo T; Lomnitski L; Nyska A; Beni S; Maronpot RR; Shohami E; Roses AD; Michaelson DM
Neuroscience; 2000; 101(4):879-84. PubMed ID: 11113336
[TBL] [Abstract][Full Text] [Related]
12. ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory.
Levi O; Jongen-Relo AL; Feldon J; Roses AD; Michaelson DM
Neurobiol Dis; 2003 Aug; 13(3):273-82. PubMed ID: 12901842
[TBL] [Abstract][Full Text] [Related]
13. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins.
Sun Y; Wu S; Bu G; Onifade MK; Patel SN; LaDu MJ; Fagan AM; Holtzman DM
J Neurosci; 1998 May; 18(9):3261-72. PubMed ID: 9547235
[TBL] [Abstract][Full Text] [Related]
14. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress.
Colton CA; Brown CM; Cook D; Needham LK; Xu Q; Czapiga M; Saunders AM; Schmechel DE; Rasheed K; Vitek MP
Neurobiol Aging; 2002; 23(5):777-85. PubMed ID: 12392781
[TBL] [Abstract][Full Text] [Related]
15. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.
Buttini M; Orth M; Bellosta S; Akeefe H; Pitas RE; Wyss-Coray T; Mucke L; Mahley RW
J Neurosci; 1999 Jun; 19(12):4867-80. PubMed ID: 10366621
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice.
Gong JS; Kobayashi M; Hayashi H; Zou K; Sawamura N; Fujita SC; Yanagisawa K; Michikawa M
J Biol Chem; 2002 Aug; 277(33):29919-26. PubMed ID: 12042316
[TBL] [Abstract][Full Text] [Related]
17. Expression of human apolipoprotein E downregulates amyloid precursor protein-induced ischemic susceptibility.
Koistinaho M; Kettunen MI; Holtzman DM; Kauppinen RA; Higgins LS; Koistinaho J
Stroke; 2002 Jul; 33(7):1905-10. PubMed ID: 12105373
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
Baum L; Chen L; Ng HK; Pang CP
Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
[TBL] [Abstract][Full Text] [Related]
19. Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy.
Williams T; Bathe T; Vo Q; Sacilotto P; McFarland K; Ruiz AJ; Hery GP; Sullivan P; Borchelt DR; Prokop S; Chakrabarty P
Acta Neuropathol Commun; 2023 Jun; 11(1):99. PubMed ID: 37337279
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice.
Sheng H; Laskowitz DT; Bennett E; Schmechel DE; Bart RD; Saunders AM; Pearlstein RD; Roses AD; Warner DS
J Cereb Blood Flow Metab; 1998 Apr; 18(4):361-6. PubMed ID: 9538900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]